Low Field and High Field Magnetic Resonance Imaging Assessments on Pediatric Patients
Hyperfine Research, Inc. has taken advantage of technological advances and developed an MRI device that is not only portable, but also uses a very-low magnetic field strength, \[less than 0.2 Tesla or approximately 10 times less\] than the field strength of conventional devices. This critical difference allows HRI to address MRI's core challenges by, first, operating at very low magnetic field strengths, eliminating the need for special rooms or shielding. Second, there are minimal safety concerns regarding ferrous metals near the system, as the field strength is too low to attract metal objects. The removal of metal, including items such as jewelry, belts, etc. from clothing and person, prior to being scanned, is unnecessary. Third, the design constraints faced by conventional MRI systems are lifted at low magnetic field and an open device has been designed to minimize anxiety that may come with claustrophobic patients. All of this is possible while still providing image quality that is clinically relevant to a wide variety of fields, including radiology, neurology, pediatrics, emergency medicine, and others.
Conditions:
🦠 Conditions Requiring a Brain Magnetic Resonance Imaging, Head Computerized Tomography, or Head Ultrasound
🗓️ Study Start (Actual)
1 October 2020
🗓️ Primary Completion (Estimated)
December 2025
✅ Study Completion (Estimated)
December 2025
👥 Enrollment (Estimated)
250
🔬 Study Type
INTERVENTIONAL
📊 Phase
NA
Locations:
📍
Kansas City, Missouri, United States
Description
- Inclusion Criteria
- Inpatients at CMH Adele Hall ages 0 days to 22 years are eligible for enrollment.
- Exclusion Criteria
- No additional sedation will be given as part of this study and that sedation, if already administered, will not be altered for study purposes.
- Any patient who has a contraindication to having an MRI, such as:
- Non-MRI conditional implanted device or device that is not able to be removed for MRI examination
Ages Eligible for Study:
0 Days to 22 Years (CHILD, ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
No
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported
results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before
being posted on the public website.
Study Registration Dates
- First Submitted
27 October 2020
- First Submitted that Met QC Criteria
13 November 2020
- First Posted
16 November 2020
Study Record Updates
- Last Update Submitted that Met QC Criteria
5 February 2024
- Last Update Posted
7 February 2024
- Last Verified
February 2024